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Abstract: Background: There is a need for instruments combining measurements of symptom distress and well-being in 
the organ transplant population. 
Objectives: The aim of this study was to describe the development and initial psychometric evaluation of a measure of 
symptoms and well-being in organ transplant recipients labelled the Organ Transplant Symptom and Well-being 
instrument (OTSWI) and to provide descriptive data on these matters. 
Method: In this cross sectional survey, the study sample (n=185) completed several measures including demographic 
information, the Short form- 36 items (SF-36), and the OTSWI to assess concurrent validity by exploring relationships 
between OTSWI and measures of health related quality of life (HRQOL). The expected scale dimensionality of the 
OTSWI questionnaire was examined both by the confirmatory multi-trait analysis program and by explorative principal 
component analysis (with oblique, varimax rotation). Scale reliability was further estimated using the Cronbach’s alpha. 
Results: There were eight factors built up from twenty of the initial fifty one items and were labelled fatigue, joint and 
muscle pain, cognitive functioning, basic activities in daily life, sleeping problems, mood, foot pain and economy. For the 
remaining twenty-one items no consistent and meaningful factors could be found leading to relevant symptoms acting as 
single items. All eight factors had satisfying internal convergent validity as well as good item-scale discriminatory validity 
or ‘success rate’. 
Discussion: Results support the internal consistency, reliability and concurrent validity of the OTSWI as an instrument to 
measure symptom distress and well-being in relation to organ transplantation. (Word count 244). 
Keywords: Organ transplantation, symptoms, psychometric evaluation, health related quality of life, well-being, nursing. 
INTRODUCTION 
  Health related quality of life (HRQOL) in organ 
transplant recipients has been extensively assessed since it 
has emerged as an important outcome measure to quantify 
the success of transplantation in the long term [1-4]. 
Forsberg [5] reported the experienced meaning of health and 
quality of life among liver transplant recipients, one year 
after the transplantation, as “the sense of freedom to choose 
to do what ever you want to do and being able to do it”[p 9]. 
Health was experienced as physical as well as mental well-
being. Factors in support of experiencing the essence of 
health and quality of life were; courage to live, hope for the 
future, having a job and feeling mentally well. Health was 
not considered being totally medically healthy. The meaning 
of quality of life (QoL) sometimes was expressed as equal to 
experiencing health in general and in particular in strong 
conjunction with stable economy. Bad economy was 
considered to be a strong obstacle to reach QoL. 
  A systematic approach to incorporate symptoms and the 
impact of side-effects from medication is however seldom  
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documented [6-7]. In an extensive review of symptom 
experience after solid organ transplantation [8] symptoms 
were related to health related quality of life and non-
adherence. Based from their review of 135 references and 18 
specific reports on symptom experience after organ 
transplantation Kugler et al., [8] concluded that further 
research should focus on the evaluation of symptom 
experiences using longitudinal designs to assess changes of 
occurrence and severity of symptoms over time. Also the 
interrelatedness between symptom experience and its 
potential impact on quality of life as well as on non-
adherence need further clarification. Special attention should 
be paid to the level of perceived symptom distress and its 
impact on the daily life of the patient as a high level of 
distress might lead to non-adherence and worse HRQoL, as 
experienced in kidney, heart and lung transplant recipients 
[9]. Kugler et al., [8] argue that little evidence is given on 
the impact of symptom experience on outcomes in terms of 
HRQoL, including emotional and functional status and 
comorbidities. 
  Neurological complications are common after organ 
transplantation and can be divided into such of those 
common to all types of transplant and others of those 
specific to transplanted organ [10]. These complications are 
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attributable to immunosuppressive drugs, followed by 
seizures, opportunistic central nervous system (CNS) 
infections, cardiovascular events, encephalopathy and de 
novo CNS neoplasms. Calcineurin inhibitors are the main 
drugs involved in neurotoxicity, leading to complications, 
which ranges from mild symptoms, such as tremors and 
parasthesia to severe symptoms, such as disabling pain 
syndrome and leukoencephalopathy [10-11]. Most of the 
instruments available aimed at assess symptom experiences 
are only focused on symptoms, and are predominantly based 
on clinical experience and expert panels [12-14]. There is a 
need for instruments combining measurements of symptom 
distress and well-being by the means of health related quality 
of life. Therefore the aim of this study was to describe the 
development and initial psychometric evaluation of a 
measure of symptoms and well-being in organ transplant 
recipients labelled the Organ Transplant Symptom and Well-
being instrument (OTSWI) and to provide descriptive data 
on these matters. 
FRAMEWORK 
  Symptom experience is a critical post-transplant 
outcome. A symptom is defined as a physical or mental 
feature, which is regarded as indicating a condition of 
disease, particularly such a feature that is apparent to the 
patient [15]. Symptoms are a regular part of the human 
experience. According to Kleinman [16], severe symptoms 
manifest as illness, which refers to how the sick person lives 
with and respond to the symptoms and disability. Symptoms 
are the most common reason why people seek health care 
and they are of vital importance in the treatment and care of 
the patients [17]. Behind the development of OTSWI there is 
a distinction between disease and illness. Disease is defined 
as an abnormality in the structure and functions of body 
organs and systems and can often be identified by signs of 
bodily disorder such as oedema or dyspnoea [18]. Illness 
means experienced reduction in states of well-being and 
social function manifesting as symptoms [18]. Disease and 
illness do not have a one-to-one relationship. Signs can be 
identified without experiences of symptoms and similar 
degrees of organ pathology can generate quite different 
symptoms i.e. graft rejection after organ transplantation. 
Illness may occur in the absence of detectable disease. 
  Symptoms might be defined as an experience reflecting 
changes in the biopsychosocial functioning, sensations or 
cognition of an individual. In contrast a sign is defined as 
any abnormality, indicative of disease that is detectable by 
the individual or by others [19]. Sometimes the symptoms 
occur in the absence of signs or they are poorly related to the 
severity of the disease [20]. 
  Symptom experience can be conceptualized by two 
different related concepts symptom occurrence and symptom 
distress [21]. Symptom occurrence can be quantified by 
frequency, severity and duration of a given symptom. 
Symptom distress refers to the emotional burden caused by a 
symptom and might be defined as the degree of discomfort, 
physical and mental upset, anguish or suffering experienced 
from a specific symptom or symptom cluster [21-22]. In 
OTSWI symptom distress is measured by degree of 
discomfort. When there are three or more concurrent and 
multiplicative symptoms related to each other they are called 
symptom cluster e.g. fatigue. The symptoms in a cluster 
must not have the same aetiology in that they can have a 
physical as well as a psychological or cognitive origin. 
  Patients suffering from symptoms need care. A 
comprehensive assessment of the symptoms experienced 
from patients perspective, followed by identification of 
strategies for interventions and evaluation of the outcomes is 
the most common way to plan and accomplish care for the 
patients [23]. The effect or outcome criterion of the 
interventions is often assessed as changes in performance, 
health related quality of life, disease progression and 
survival [24-25]. The goal of organ transplantation is not 
merely survival, but to give the individual the best HRQoL 
possible. In the OTSWI the outcome criterion is well-being 
by the means of health related quality of life involving 
physiological, emotional, social and behavioural 
components. The basic assumption behind OTSWI is that 
well-being is present in the absence of fatigue, joint and 
muscle pain, sleeping problems, mood problems, foot pain 
and worries about economy as well as in the absence of 
impairments regarding cognitive functioning and basic 
activities in daily life. In this instrument well-being and 
health related quality of life are viewed synonymously. 
Health related quality of life (HRQoL) refers to a person’s 
subjective evaluation of the influence of their current health 
status, health care, and health promoting activities on their 
ability to achieve and maintain a level of overall function 
that allows them to pursue valued life goals and that is 
reflected in their general well-being [26]. HRQoL is 
determined by emotional well-being and social, physical and 
cognitive functioning. Forsberg [5] have suggested the 
application of this HRQoL-definition on liver transplant 
recipients as follows. The transplant recipient’s current 
health status, i.e. presence of graft rejection, infection or 
surgical complication influences, and is influenced by the 
health care provided such as medication, patient education or 
mental support. The individual ability to perform health-
promoting activities, for example physical exercise and 
adherence with medication, affects the ability to achieve and 
maintain a level of overall functioning. The result of this 
process finally affects the person’s ability to pursue valued 
life goals that in the end reflects their general well-being. 
Factors that determine HRQoL are emotional and social 
well-being as well as physical and cognitive functioning. 
Spiritual and socio-economic dimensions may affect the 
whole concept of HRQoL. The OTSWI doesn’t include 
spiritual dimensions however; physical and cognitive 
functioning, emotional well-being as well as socio-economic 
dimension that determine HRQoL are covered. Social well-
being and physical functioning will be included in the 
instrument during further development. 
METHODOLOGY 
Subjects and Procedures 
  In this cross sectional survey, questionnaires were mailed 
in February 2008 to organ transplant recipients (OTRs), 
transplanted at the Sahlgrenska University Hospital in 
Gothenburg, Sweden. Participants were included through an 
existing register including all OTRs. The invited study group 
included 229 OTRs between 19-65 years old, transplanted 
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(n=32). This distribution between organ transplantation 
reflects the reality at this centre; kidney transplant recipients 
(KTRs) are the largest group of transplanted patients and 
then liver transplant recipients (LTRs) and the smallest 
group are heart transplant recipients (HTRs) and lung 
transplant recipients (LUTRs). All patients with a recovery 
period of 1year +/- 3 months and 3 years +/- 3 months after 
transplantation were included. This criterion was applied in 
order to catch those with a relatively recent transplantation 
and those who have had their transplant for a longer time. 
Clinical and demographic data were collected in the set of 
questionnaires. Data included type of organ transplanted and 
date of transplantation, number of graft rejections, age, sex, 
marital and occupational status. After the first mailing, 162 
participants responded. A reminder was mailed in May 2008, 
increasing the number of responders to 185 participants. This 
means a final response rate of 81% (185 of 229). 
Questionnaires 
Organ Transplant Symptom and Well-Being Instrument 
(OTSWI) 
  The development of the questionnaire OTSWI, which is 
developed to measure symptom prevalence, symptom 
distress and level of well-being, has followed the steps 
described by Juniper, Guyatt and Jaeschke [27] in Table 1. 
Each response relates to how much the problem or situation 
discomforts you, assessed on a five-point scale ranging from 
“not at all”(0), “a little”(1), “somewhat”(2), “quiet a bit”(3) 
and “very much” (4). Time was specified to a time frame of 
one week. 
Short Form Health Survey SF-36 
  The Swedish version of the SF-36 questionnaire, which 
measures health status, was used to validate the OTSWI 
questionnaire [28]. The SF-36 measures eight health 
domains: Physical functioning (PF), Role limitations due to 
physical problems (RP), Bodily pain (BP), General health 
(GH), Vitality (VT), Social functioning (SF), Role limitations 
due to emotional problems (RE) and Mental health (MH). 
The scores range from 0-100 on all scales with higher scores 
indicating a better HRQoL. The SF-36 also provides two 
summary measures; Physical Component Score (PCS) and 
Mental Component Score (MCS) [28]. 
Determining Validity of the OTSWI 
  Data was analysed with SPSS version 15.0 and the Multi-
trait Analysis Program – version 2 [29]. The expected scale 
dimensionality of the OTSWI questionnaire was examined 
both by the confirmatory multi-trait analysis program and by 
Table 1.  The Steps of Development and Testing the Instrument Organ Transplant Symptom and Wellbeing Instrument (OTSWI) 
Suggested by Juniper, Guyatt and Jaeschke [27] 
 
A. Development 
Step   Task  Performance 
1  Specifying 
measurement goals 
OTSWI was developed to be used for adult persons waiting for or have undergone solid organ transplantation (OT). 
They should be able to read and write Swedish or any other relevant language that the instrument is translated to. The 
primary purpose of the instrument is to be discriminative and evaluative. All areas of dysfunction associated with solid 
OT are included. The instrument is supposed to be self -administered, but will also be suitable for telephone interviews. 
2 Item  generation  Item pool was chosen from unstructured interviews, studies regarding health related quality of life (HRQOL), review of 
the transplant specific literature; discussions with transplant professionals and finally a review of generic HRQOL 
instruments. 
4 Item  reduction  The initial version included in a total 51 items. There were 28 items focused on symptoms, 8 items on physical 
functioning, 8 on emotional aspects and 7 items on social and financial aspects. The items were reduced by factor 
analysis based at 185 organ transplant recipients reported in Table 2. Finally the items were grouped into domains and 
labelled by a combination of their content, clinical experience and common sense. 
4  Questionnaire 
formatting 
Words were used that apply to the widest range of cultures and geographic areas in order to facilitate translation and 
widespread use. Each response relates to how much the problem or situation discomforts you, assessed on a five-point 
scale ranging from “not at all”(0), “a little”(1), “somewhat”(2), “quiet a bit”(3) and “very much” (4). Time was 
specified to a time frame of one week.  
B. Testing 
5  Pretesting  A small pretest was performed involving ten organ transplant recipients (OTR).  
6 Reliability  Scale reliability was estimated using the Cronbach’s alpha. Reliability in terms of the relationship between the signal, 
in this case the difference between subjects, and the noise, the difference within a subject when the clinical state is 
stable will be tested by further research. 
7 Responsiveness  To test if the instrument is responsive to the true change occurring in a patient over a period of time further research 
will be needed. 
8 Validity  Validity was determined by the confirmatory multi-trait analysis program and by explorative principal component 
analysis (with oblique, varimax rotation). Construct validity was determined by examining the relation between 
OTSWI and the generic HRQOL-instrument SF-36. 
9 Interpretability  We will use the so called anchor-based approach, where the changes in quality of life measures are compared, or 
anchored to other clinically meaningful outcomes. This will be tested further. In this study clinically meaningful 
outcomes were considered to be time since transplantation, number of graft rejections, type of organ and graft function 
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explorative principal component analysis (with oblique, 
varimax rotation). In the multi-trait analysis program the 
hypothesized internal item-scale structure is examined, i.e. 
convergent and discriminatory validity. Convergent validity 
refers to the consistency of the items expected to measure a 
scale (factor). This was tested by computing the item 
correlations with their expected factor, corrected for overlap. 
A common criterion is item-scale correlations of at least 0.40 
[29] Discriminatory validity was tested by computing the 
proportion of items that correlated higher or significantly 
higher with their expected (hypothesized) scale compared 
with the other scales (success rate). In the explorative 
principal component analysis, three strategies were used 
interactively to determine the number of tentative factors to 
retain - Cattell's scree plot, absorption of variance and 
meaningfulness of factors [30]. The item-scale structure that 
was the best compromise between the results of the multi-
trait analysis and the explorative factor analysis was finally 
retained. Scale reliability was further estimated using the 
Cronbach’s alpha. According to conventional rule this 
coefficient should at least exceed 0.70 [31]. Construct 
validity was tested by examining the relation between scores 
on the OTSWI and the generic HRQoL-instrument SF-36. 
  When analysing differences between two unpaired 
groups independent t-test were performed, and between three 
unpaired groups one-way ANOVA was performed. To 
investigate relationships Pearson correlations were 
calculated. The Ethics committee of Gothenburg University 
approved the study and the participants gave their written 
consent to participate. 
RESULTS 
Clinical and Demographic Variables 
  A majority of the participants were male (62%) and most 
of the total group were working (46%) or on disability 
pension (35%). A total of 66% were cohabitant or married. 
According to the selection, the distribution between the 
organ transplanted recipients reflected the reality at our 
center with 63% KTRs, 21% LTRs and 15% receiving a 
heart or a lung. Detailed demographics of the study 
participants are shown in Table 2. 
Obtained Factors in the OTSWI Questionnaire 
  There were eight factors verified by the psychometric 
tests developed to measure well-being. These eight factors 
were built up from twenty of the fifty-one items and were 
labelled fatigue (3 items), joint and muscle pain (3 items), 
cognitive functioning (2 items), basic activities in daily life 
(BADL) (3 items), sleeping problems (3 items), mood (2 
items), foot pain (2 items) and economy (2 items). For the 
remaining twenty-one items no consistent and meaningful 
factors could be found leading to relevant symptoms acting 
as single items. In the explorative principal component 
analyses this eight-factor solution was supported by the 
following tests. Together the eight factors accounted for 86 
% of the variance of the initial fifty-one items. Cattell's scree 
plot flattened out after the eighths factor and the items with 
the highest loadings on each factor were homogenous and 
meaningful in content. All eight factors also had eigen-
values above one [28]. In the tests of convergent and   
 
discriminatory validity with the multi-trait analysis program 
it was found that all eight factors had satisfying internal 
convergent validity as well as good item-scale 
discriminatory validity or ‘success rate’. Item scale 
correlations, corrected for overlap, ranged from 0.66 to 0.98 
as shown in Table 3. The related measure of item 
consistency, the Cronbach’s alpha coefficient, was good for 
all scales (Table 3). 
Table  2.  Demographics Among 185 Organ Transplant 
Recipients 
 
Male 
Female 
62 % (n=114) 
38 % (n=71) 
Age < 50 yr 
Age > 50 yr 
42 % (n=77) 
58 % (n=108) 
Working 
Studying 
Retired 
Disability pension 
Sick-leave  
Unemployed 
Other 
46 % (n=85) 
2 % (n=3) 
1 % (n=2) 
35 % (n=64) 
12 % (n=22) 
2 % (n=4) 
2 % (n=4) 
Single 
Co-habitant/Married 
34 % (n=61) 
66 % (n=122) 
Kidney Transplant Recipients (KTR) 
Liver Transplant Recipients (LTR) 
Heart/Lung Transplant Recipients (HLTR) 
63 % (n=117) 
21 % (n=39) 
16 % (n=29) 
Time since tx; 1year +- 3 month 
Time since tx; 3 year +- 3 month 
58 % (n=107) 
42 % (n=78) 
Number of patients having a rejection  38 % (n=70) 
 
  Results of the test for construct validity are given in 
Table 4 where reasonable relations were found between the 
eight factors in OTSWI and SF-36 in all relevant areas 
except between basic activities in daily life and physical 
functioning (Table 4). After reduction of 11 items that 
showed no meaningful correlation to any of the other items, 
in a total twenty single items remained measuring symptom 
prevalence and symptom distress as reported in Table 5. 
When measuring relations between single symptoms and SF-
36 (Table 6) we only report correlations where at least one 
value is of .40 and above since this cut off represent a 
moderate correlation. The symptoms in Table 6 were 
selected since median level was reported as a little bit 
(median 1) indicating slight distress. Regarding the rest of 
the symptoms, also maintained in the instrument, the median 
level was 0 (not at all) and therefore not reported in the table. 
Descriptive Data Regarding OTRs Experienced Well-
Being 
  The data were skewed in all areas reported by OTSWI 
where descriptive data are given in Tables 7 and 8. The 
reason for this descriptive part is to provide data for future 
comparison when further testing and using the OTSWI.   
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There were three areas where the whole group reported worst 
well-being. In the first area, sleep problems (median 3= quite 
a bit) 79% reported the symptom and of those 27% were 
severely bothered. In the second area, fatigue (median 2= 
some what) 67% reported the symptom and among those 
29% had severe problems. Finally 68% reported muscle and 
joint pain (median 2) where 16% had severe pain. The 
symptoms where median level was reported as a little bit 
(median 1) were dyspnoea (51%), trembling hands (53%), 
increased appetite (56%), and decreased libido (58%). 
Table 3.   The Factor Structure by the Use of Oblique Varimax Rotation 
 
Factors in OTSWI  Item  Item Scale Correlation  Cronbach’s Alfa 
I am physically tired  .81 
I have no energy  .82  1. Fatigue (F) 
I feel lazy and listless  .83 
.90 
My muscles are aching  .81 
My joints are aching  .79  2. Joint and muscle pain (JMP) 
My legs are aching  .72 
.87 
I have difficulties to remember  .89 
3. Cognitive functioning (CF) 
I find it hard to concentrate  .66 
.84 
Due to my physical condition I can’t get dressed by myself   .98 
Due to my physical condition I can’t take a bath or shower   .96  4. Basic ADL (BADL) 
Due to my physical condition I can’t buy food by my self   .84 
.92 
I have difficulties with falling asleep   .87 
I sleep poorly  .88  5. Sleeping problems (SP) 
I wake up during the night  .83 
.89 
I feel irritated  .74 
6. Mood (M) 
I feel angry   .86 
.82 
There is a burning ache in my feet  .86 
7. Foot pain (FP) 
There is a numb and stabbing feeling in my feet  .88 
.81 
 I worry about not being able to keep my job due to my health condition   .88 
8. Economy (E) 
I worry about my economy due to my health condition .84 
.81 
 
Table 4.  Pearson Correlations Between the Factors of Organ Transplant Symptom and Wellbeing Instrument (OTSWI) and Short 
Form Health Survey SF-36 Measuring Eight Health Domains 
 
OTSWI 
SF-36 
Fatigue   Joint and Muscle Pain   Cognitive Functioning   Basic ADL  Sleeping Problems  Mood  Foot Pain  Economy 
PF -.60**  -.46**  -.25**  -.26**  -.35**  -.23** -.36**  -.37** 
RP -.67  **  -.41**  -.39**  -.18*  -.35**  -.33**  -.31**  -.44** 
BP -.39**  -.61**  -.34**  -.14  -.34**  -.29**  -.36**  -.30** 
GH -.55**  -.35**  -.43**  -.08  -.28**  -.35**  -.22**  -.46** 
VT -.76**  -.40**  -.54**  -.11  -.39**  -.42**  -.30**  -.46** 
SF -.60**  -.36**  -.49**  -.12  -.38**  -.46** -.29**  -.51** 
RE -.57**  -.29**  -.41**  -.17*  -.29**  -.38**  -.25**  -.33** 
MH -.50**  -.28**  -.50**  -.05  -.38**  -.53**  -.22**  -.44** 
PCS -.60**  -.55**  -.29**  -.21**  -.35**  -.22**  -.36**  -.40** 
MCS -.57**  -.24**  -.54**  -.06  -.35**  -.53**  -.21**  -.42** 
Physical functioning (PF), Role limitations due to physical problems (RP), Bodily pain (BP), General health (GH), Vitality (VT), Social functioning (SF), Role limitations due to 
emotional problems (RE) and Mental health (MH) and two summary measures; Physical component Score (PCS) and Mental component score (MCS). 
*= Significance at .05-level. 
** = Significance at.01-level. The Organ Transplant and Well-Being Instrument  The Open Nursing Journal, 2012, Volume 6    35 
Regarding the rest of the 16 symptoms the median level was 
0 meaning not at all. 
Differences in Perceived Well-Being Between Organ 
Transplants 
  When analysing differences in well-being between the 
various organ groups there were no differences found in the 
eight factors in the OTSWI. Regarding symptoms, measured 
by single items, liver transplant recipients (LTR) were 
significantly more sad (p=.005) than those receiving a 
kidney or a heart and/or lung. There were also some 
tendencies noticed were LTRs reported more fatigue (p=.07) 
than the other two groups as well as more pain in the joints 
Table 5.  Twenty Items Measuring the Prevalence of Symptoms and Level of Symptom Distress in the Organ Transplant Symptom 
and Well-Being Instrument (OTSWI) 
 
  Symptoms  Not at All 
0 
A Little Bit 
1 
Some What 
2 
Quite a Bit 
3 
Very Much 
4 
1  I am breathless  0  1  2  3  4 
2  I need to rest because I am breathless  0  1  2  3  4 
3  I’m  swollen  0 1 2 3 4 
4  I feel nauseous  0  1  2  3  4 
5  I have oral fungus  0  1  2  3  4 
6  I have oral herpes  0  1  2  3  4 
7  I have increased appetite for food  0  1  2  3  4 
8  I have decreased appetite for food  0  1  2  3  4 
9  I have dyspepsia   0  1  2  3  4 
10  I’m  constipated  0 1 2 3 4 
11  I have diarrhea  0  1  2  3  4 
12  My skin is itching   0  1  2  3  4 
13  I have headache  0  1  2  3  4 
14  There is a burning pain in my hands   0  1  2  3  4 
15  There is a numb and stabbing pain in my hands   0 1 2 3 4 
16  My hands are trembling  0  1  2  3  4 
17  I feel dizzy  0  1  2  3  4 
18  I feel sad  0  1  2  3  4 
19  My looks makes me embarrassed   0  1  2  3  4 
20  My libido is decreased  0  1  2  3  4 
Each response relates to how much the problem or situation discomforts you, assessed on a five-point scale ranging from “not at all”(0), “a little”(1), “somewhat”(2), “quiet a bit”(3) 
and “very much” (4). 
 
Table 6.  Pearson Correlations Between Selected Symptoms Measured by Organ Transplant Symptom and Wellbeing Instrument 
(OTSWI) and Short Form Health Survey SF-36 Measuring Eight Health Domains 
 
OTSWI 
SF-36 
Dyspnoea   Oedema  Dizzieness  Sadness  Decreased Libido  Embarrassed by Looks 
PF -.63**  -.48**  -.38**  -.35** -.37**  -.29** 
RP -.53  **  -.33**  -.36**  -.48*  -.43**  -.32** 
BP -.35**  -.39**  -,20**  -.28**  -.29**  -.16* 
GH -.46**  -.25**  -.25**  -.46**  -.42**  -.22** 
VT -.58**  -.44**  -.44**  -.56**  -.45**  -.33** 
SF -.49**  -.33**  -.35**  -.57** -.50**  -.36** 
RE -.32**  -.26**  -.35**  -.64**  -.39**  -.33** 
MH -.34**  -.28**  -.32**  -.70**  -.36**  -.40** 
PCS -.60**  -.43**  -.30**  -.27**  -.39**  -.20** 
MCS -.32**  -.25**  -.35**  -.75**  -.42**  -.39** 
Physical functioning (PF), Role limitations due to physical problems (RP), Bodily pain (BP), General health (GH), Vitality (VT), Social functioning (SF), Role limitations due to 
emotional problems (RE) and Mental health (MH) and two summary measures; Physical component Score (PCS) and Mental component score (MCS).  
*= Significance at .05-level. 
** = Significance at.01-level. 36    The Open Nursing Journal, 2012, Volume 6  Forsberg et al. 
(p=.06). LTRs also reported more headache (p=.09) and 
dizziness (p=.09) however not significant. 
Differences in Well-Being Due to Age, Gender, Time 
Since Transplantation and Having a Rejection or Not 
  Patients younger than 50 years reported significantly more 
problems with irritation and aggressive mood (p=.03) as well as 
with heart burn (p=.03). Tendencies in differences due to age 
were noticed regarding basic activities in daily life where 
patients older than 50 years reported more problems (p=.06) as 
well as regarding decreased libido (p=.07). Patients below 50 
years, tended to report more tremor (p=.09). 
  When comparing differences due to gender, women 
reported more sleep problems (p=.004) and joint pain (p=.01). 
Female OTRs had more oedema (p=.006), were more nauseas 
(p=.02) and more dizzy (p=.000) than male OTRs. Finally the 
women were significantly more sad (p=.03), had less libido 
(p=.01) and were more bothered by their physical appearance 
(p=.006) than the male OTRs. 
  There were no differences between the OTRs with a follow 
up of one year and those transplanted more than three years 
except for two symptoms. The patients with a short follow-up 
reported more diarrea (p=.05) and those with a longer follow-up 
reported more itching (p=.03). No differences were found in any 
area or any single symptom between those who had experienced 
one or more graft rejections and those who hadn’t. 
DISCUSSION 
Methodological Considerations 
  In the literature there are eight attributes for instrument 
properties to be used in the evaluation regarding sustainability 
for distribution to the target population. These eight attributes 
are: conceptual and measurement model, reliability, validity, 
responsiveness, interpretability, respondent and administrative 
burden, alternative forms and cultural and language adaptations 
[32]. Other researchers have defined similar, but less 
comprehensive quality criteria [33-34]. A part from evaluation 
of validity and reliability, a clear description of measurement 
aims, target population, the concept of interest (theoretical 
framework), item selection, item reduction and the workload 
required from respondents to complete the questionnaire should 
be provided when developing a new questionnaire [35]. We 
argue that the above mentioned quality criteria are fulfilled 
regarding OTSWI with the exception of reliability which is not 
yet fully tested. As mentioned in Table 1, reliability in terms of 
the relationship between the signal, in this case the difference 
between subjects, and the noise, the difference within a subject 
when the clinical state is stable will be tested by further 
research. Also to test if the instrument is responsive to the true 
change occurring in a transplanted patient over a period of time 
further research will be needed. 
  A methodological or a psychometrical error was noticed 
when finding out the weak correlation values between the 
domain physical functioning in SF-36 and Basic Activities in 
daily life in OTSWI. At first we hade viewed the domain 
BADL as similar to PF, however when scrutinizing the items 
in the BADL-domain they are not at all similar to PF. Instead 
they measure factors completely related to activities in daily 
life functioning. Items regarding actual physical functioning 
were removed during the test using Cronbach’s Alfa since 
the alfa-values were so high that only a few items were 
needed. When further test will be performed a domain 
comprising physical functioning will be added and tested. 
Also a domain more explicitly comprising the social well-
being dimension will be developed by further test. In the 
present version the social well-being are more implicit 
involving ability to work and libido. Despite these errors we 
conclude that the development procedure, which has lasted 
for over five years, has been successful so far and that the 
OTSWI might be used in the target population for various 
longitudinal follow-up. 
Discussion Regarding Descriptive Findings 
  The patients were bothered somewhat (median 2) by 
fatigue and quite a bit (median 3) by sleeping problems. 
Today we don’t know enough about fatigue after organ 
transplantation, whether the sleeping problems cause fatigue 
or about how the patients master this symptom. In other 
patient groups with chronic heart failure and myocardial 
infarction it has been shown that other variables i.e. low 
haemoglobin levels, depressed mood, anxiety and 
uncertainty were associated with different dimensions of 
fatigue [36-37]. Falk [36] also showed that nausea, poor 
appetite and bodily pain associated with fatigue even if they 
were not the most dominating symptoms. Further studies are 
Table  7.  Descriptive Data on Well-Being Measured by the Organ Transplant Symptom and Wellbeing Instrument (OTSWI) 
Among 185 Organ Transplant Recipients. 
 
Factors of Well-Being 
 Fatigue    Joint and 
Muscle Pain  
Cognitive 
Functioning   Basic ADL  Sleeping 
Problem  Mood Foot  Pain  Economy 
Mean  2,64 2,41 1,73 0,72 3,32 1,01 1,03 1,91 
Median  2,00  2,00  1,00 0 3,00 0  0  1 
SD  2,92 2,84 1,93 2,25 3,30 1,49 1,79 2,36 
Skewness  1,25 1,58 1,27 3,70 1,16 1,88 2,20 1,40 
Min  0 0 0 0 0 0 0 0 
Max  12 12  8  12 12  7  8  8 
Each response relates to how much the problem or situation discomforts you, assessed on a five-point scale ranging from “not at all”(0), “a little”(1), “somewhat”(2), “quiet a bit”(3) 
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needed regarding the relationship with fatigue and other 
conditions and symptoms. 
  Fatigue in healthy individuals was decribed by Grandjean 
[38] as a non-specific state indicative of decreased level of 
vitality, which is supported by our study, where fatigue were 
associated with low physical functioning, role-physical, vitality 
and social functioning as reported in Table 4. This state has a 
protective function of forcing the body to avoid further stress, 
with exhaustion being the end of the fatigue continuum. This 
temporary form of fatigue is identified as acute and 
characterized as protective and identifiably linked to a single 
and obvious cause. In our study the patients had been 
transplanted for quite a while. According to Piper [39] chronic 
fatigue is referring to a state where the fatigue is accompanied 
by diseases. It then becomes a symptom that is complex, 
multicausal and multidimensional that is difficult to characterize 
and define. Fatigue is one of the most frequently reported 
symptoms in many chronic illnesses, including cancer [40], 
renal failure [41], chronic pulmonary disease [42], multiple 
sclerosis [43] and rheumatoid arthritis [44]. The point regarding 
organ transplant recipients is that their previous chronic disease 
is managed and improved although not always cured by the 
transplantation. The organ transplant recipients are able to live a 
normal life although with a chronic medical treatment to prevent 
rejection of the transplanted organ and other medication to 
manage co-morbidities e.g. hypertension. The findings in our 
study emphasizes the importance of comprehensive assessment 
and a broad approach to interventions during follow-up visits in 
the out patient clinic, because reduction of fatigue may get 
through alleviation of more manageable influencing symptoms 
i.e. possible anxiety and depression. One might start with 
assessing and treating the sleeping problems reported as 
something that affects daily life, and not look away from the 
fact that fatigue is reported as a key factor leading to decreased 
quality of life in patients with chronic diseases [20]. 
  Dysponea as a single symptom correlated strongly with 
decreased physical functioning as well as the physical 
component score measured by SF-36. In return, sadness 
correlated strongly with low mental health as well as the 
mental component summary (Table 6). However, these 
symptoms were reported as minor distressing, dysponea 
(median 1, a little bit) and sadness (median 0, not at all). A 
reasonable explanation might be that these symptoms 
strongly affect HRQoL for those who are suffering, however 
in general these symptoms are not an issue for the whole 
transplant population. 
Table  8.  Descriptive Data on Symptoms Measured by the Organ Transplant Symptom and Wellbeing Instrument (OTSWI) 
Among 185 Organ Transplant Recipients 
 
Symptoms 
  Dysponea  Oedema  Nausea  Oral Fungus  Oral Herpes  Increased 
Appetite 
Loss of 
Appetite  Heart Burn 
Mean  0,78 0,68 0,25 0,13 0,09 0,94 0,26 0,43 
Median  1 0 0 0 0 1 0 0 
SD  0,97 0,91 0,52 0,46 0,28 1,12 0,68 0,82 
Skewness  1,36 1,60 2,29 4,20 2,94 1,42 2,86 2,42 
Min  0 0 0 0 0 0 0 0 
Max  4 4 3 3 1 6 4 4 
Symptoms 
 Diarrea  Itching  Headache  Burning 
Hands  Tremor Dizzy  Sad Decreased 
Libido 
Mean  0,42 0,43 0,51 0,11 0,76 0,41 0,59 1,26 
Median  0 0 0 0 1 0 0 1 
SD  0,78 0,80 0,81 0,46 0,90 0,69 0,89  1,4 
Skewness  1,99 2,19 2,06 4,64 1,34 2,01 1,80 0,82 
Min  0 0 0 0 0 0 0 0 
Max  4 4 4 3 4 4 4 4 
Symptoms 
 Physical  Appearance 
Mean 0,44 
Median 0 
SD 0,97 
Skewness 2,5 
Min 0 
Max 4 
Each response relates to how much the problem or situation discomforts you, assessed on a five-point scale ranging from “not at all”(0), “a little”(1), “somewhat”(2), “quiet a bit”(3) 
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  There were only weak relationships between the dimensions 
measured by SF-36 and the symptom embarrassed by looks. In 
another study [45] involving 108 liver transplant recipients, the 
most frequent symptom in male and female recipients were 
increased hair growth. Women with a long-term follow up (5-18 
years) reported more cosmetic side-effects and over all 
symptom distress was more serious in women than in men. In 
our study the symptom physical appearance was not at all 
(median 0) distressing in the whole group, but the female 
patients were more embarrassed by their looks than the male 
patients (p=.006). Also several other symptoms were more 
distressing among females i.e. nausea, oedema and decreased 
libido. Regarding decreased libido, sexual dysfunction and sex 
hormone disturbances are widely reported in men and women 
before organ transplantation e.g. patients with chronic liver 
disease. Successful liver transplantation leads to improvements 
in sex hormone disturbances in both men and women, but 
immunosuppressive drugs may interfere with hormone 
metabolism [46]. Health issues, medications, aging and 
psychological and social issues, might affect post transplant 
sexual health. In a study by Ho, Ko, Schaeffer et al., [47] 23% 
of males and 26% of females reported decreased libido. This 
picture that women overall experience more symptoms than 
men is supported by numerous studies reported in the extensive 
review by Kugler et al., [8], however no conclusive discussion 
about why female organ transplant recipients experience more 
symptom distress than males are presented. Thus, this is an area 
for further research. 
  Besides problems with sleep and fatigue the most 
prominent symptom causing distress was muscle and joint 
pain. This is in line with a previous study [48] reporting that 
53% of the organ transplant recipients reported pain to some 
extent and that the most common pain locations were hands 
and feet followed by the back. This symptom might be caused 
by the so called Calcineurin Inhibitor Pain Syndrom reported 
by Grotz et al., [11] and further discussed as neurological 
complications by Senzolo, Ferronato and Burra [10]. 
  Drawing firm conclusions from this single study on 
symptom experience, symptom distress and well-being is of 
course difficult. In line with previous knowledge, the results 
indicate that few symptoms actually cause distress in daily 
life among organ transplant recipients. New information 
involve that sleeping problems were most disturbing 
followed by fatigue and muscle and joint pain. Dyspnoea, 
increased appetite, decreased libido and tremor affected the 
patients only a little bit. Fatigue correlated moderately or 
strongly with almost all dimensions of importance in 
HRQoL reported by SF-36. Further studies should focus on 
the fatigue in particular as well as the relationship between 
symptom distress and HRQoL. 
CONCLUSION 
  Fatigue might be a key factor leading to a decreased 
HRQoL not only in patients with chronic diseases, but also 
for organ transplant recipients with prerequisites to be well 
and experience good HRQoL. The newly developed 
instrument labelled the Organ Transplant Symptom and 
Well-being Instrument offer a possibility to include both 
symptoms occurrence, symptom distress and health related 
quality in the measurements. Now transplant nurses have a 
useful tool to assess post transplant patients and plan their 
goal directed nursing interventions in collaboration with the 
patients concerned. 
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APPENDIX 
The Organ Transplant Symptom and Wellbeing Instrument (OTSWI) 
  Below there is a list of statements that other persons, with the same health condition as you, consider important. Please state how 
well each statement reflects your situation during the last seven days.  Please mark the most suitable figure at each line. 
 
   Not at All 
0 
A Little 
1 
Somewhat  
2 
Quiet a Bit 
3 
Very Much 
4 
1  I have difficulties with falling asleep  0  1  2  3  4 
2  I sleep poorly  0  1  2  3  4 
3  I wake up during the night  0  1  2  3  4 
4  My muscles are aching  0  1  2  3  4 
5  My joints are aching  0  1  2  3  4 
6  My legs are aching  0  1  2  3  4 
7  There is a burning ache in my feet  0  1  2  3  4 
8  There is a numb and stabbing feeling in my feet  0  1  2  3  4 
9  I am physically tired  0  1  2  3  4 
10   I have no energy  0  1  2  3  4 
11  I feel lazy and listless  0  1  2  3  4 The Organ Transplant and Well-Being Instrument  The Open Nursing Journal, 2012, Volume 6    39 
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   Not at All 
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A Little 
1 
Somewhat  
2 
Quiet a Bit 
3 
Very Much 
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